SG Americas Securities LLC boosted its holdings in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report) by 6.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,392 shares of the company’s stock after acquiring an additional 193 shares during the quarter. SG Americas Securities LLC’s holdings in Direxion Daily S&P Biotech Bull 3x Shares were worth $305,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Tidal Investments LLC bought a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 3rd quarter worth $9,012,000. Traynor Capital Management Inc. lifted its holdings in shares of Direxion Daily S&P Biotech Bull 3x Shares by 6.7% during the third quarter. Traynor Capital Management Inc. now owns 10,763 shares of the company’s stock valued at $1,386,000 after purchasing an additional 674 shares during the last quarter. JPMorgan Chase & Co. boosted its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 129.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,851 shares of the company’s stock valued at $625,000 after purchasing an additional 2,735 shares during the period. McGuire Investment Group LLC increased its stake in Direxion Daily S&P Biotech Bull 3x Shares by 3.9% in the 3rd quarter. McGuire Investment Group LLC now owns 4,633 shares of the company’s stock worth $596,000 after purchasing an additional 175 shares in the last quarter. Finally, Foundations Investment Advisors LLC increased its stake in Direxion Daily S&P Biotech Bull 3x Shares by 13.0% in the 3rd quarter. Foundations Investment Advisors LLC now owns 4,617 shares of the company’s stock worth $594,000 after purchasing an additional 530 shares in the last quarter.
Direxion Daily S&P Biotech Bull 3x Shares Stock Up 3.6 %
LABU stock opened at $95.15 on Wednesday. Direxion Daily S&P Biotech Bull 3x Shares has a one year low of $78.46 and a one year high of $176.99. The firm has a 50-day moving average of $100.24 and a two-hundred day moving average of $118.46.
Direxion Daily S&P Biotech Bull 3x Shares Company Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Recommended Stories
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- When to Sell a Stock for Profit or Loss
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- Where Do I Find 52-Week Highs and Lows?
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Stock Splits, Do They Really Impact Investors?
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report).
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.